A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Clinical trial NCT05944224 · RECRUITING
Trial details
- NCT number
- NCT05944224
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2026-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.